Avricore Health Inc. Form 6-K Filing

This filing is a report of Avricore Health Inc. for May 2026, including notices for an upcoming Annual General Meeting (AGM) on June 18, 2026. Key events include a $1.25 million financing through a private placement to expand the HealthTab™ network and for general working capital. The financing involves the issuance of units, each comprising a common share and a half warrant. Directors and officers are expected to participate in the private placement. The filing also details the agenda for the AGM, which includes receiving financial statements for the year ended December 31, 2025, fixing the number of directors, electing directors, and appointing auditors. Information on executive and director compensation for the fiscal year ended December 31, 2025, is provided, along with details on outstanding stock options and awards. The company is focused on its HealthTab™ platform for community-based point-of-care testing.